These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 227906)

  • 1. Genetical analysis on the stability of poliovirus type 3 Leon 12a1b.
    Nakano M; Matsukura T; Yoshii K; Komatsu T; Mukoyama A; Uchida N; Kodama H; Tagaya I
    J Biol Stand; 1979 Jul; 7(3):157-68. PubMed ID: 227906
    [No Abstract]   [Full Text] [Related]  

  • 2. Pattern of plaquing efficiency at different temperatures (PPET) as a differentiation tool among poliovirus type 3 Leon 12a1b progenies and its possible use as a genetic marker.
    Yoshii K; Matsukura T; Nakano M; Tagaya I
    J Biol Stand; 1979 Jul; 7(3):169-78. PubMed ID: 227907
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.
    Chumakov KM; Powers LB; Noonan KE; Roninson IB; Levenbook IS
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):199-203. PubMed ID: 1846038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated oral poliovirus vaccine.
    Melnick JL
    Rev Infect Dis; 1984; 6 Suppl 2():S323-7. PubMed ID: 6330836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of safety and potency tests of vaccines against poliomyelitis.
    Elisberg BL
    Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850
    [No Abstract]   [Full Text] [Related]  

  • 6. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.
    Svitkin YV; Cammack N; Minor PD; Almond JW
    Virology; 1990 Mar; 175(1):103-9. PubMed ID: 2155504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of the attenuated poliovirus type 3 vaccine strain by sucrose.
    Srivastava AK
    Acta Virol; 1989 Mar; 33(2):188-90. PubMed ID: 2569817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the attenuation of the Sabin type 3 oral polio vaccine.
    Almond JW; Westrop GD; Evans DM; Dunn G; Minor PD; Magrath D; Schild GC
    J Virol Methods; 1987 Aug; 17(1-2):183-9. PubMed ID: 2822753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On stability of oral poliovirus vaccines.
    Mauler R; Gruschkau H
    Dev Biol Stand; 1978; 41():267-70. PubMed ID: 38157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells.
    Mann GF; de Mucha J
    Dev Biol Stand; 1976 Dec 13-15; 37():255-8. PubMed ID: 201522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.
    Stanway G; Hughes PJ; Mountford RC; Reeve P; Minor PD; Schild GC; Almond JW
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1539-43. PubMed ID: 6324200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines.
    Marsden SA; Boulger LR; Magrath DI; Reeve P; Schild GC; Taffs LF
    J Biol Stand; 1980; 8(4):303-9. PubMed ID: 7009616
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a mathematical model for neurovirulence assay of attenuated poliovirus.
    Arya SC
    J Biol Stand; 1977; 5(4):283-7. PubMed ID: 200629
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
    Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW
    Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated oral poliovirus vaccine: problem areas in production.
    Beale AJ
    Rev Infect Dis; 1984; 6 Suppl 2():S334. PubMed ID: 6429813
    [No Abstract]   [Full Text] [Related]  

  • 16. The behaviour of Sabin attenuated poliovirus strains in the central nervous system of rhesus monkeys.
    Arya SC
    J Biol Stand; 1977; 5(4):275-81. PubMed ID: 200628
    [No Abstract]   [Full Text] [Related]  

  • 17. Standardization of reference preparations-factors influencing assay of attenuated polioviruses.
    Arya SC
    Indian J Med Res; 1975 May; 63(5):625-30. PubMed ID: 1213762
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines.
    Ogra PL; Faden HS; Abraham R; Duffy LC; Sun M; Minor PD
    J Infect Dis; 1991 Jul; 164(1):191-4. PubMed ID: 1647422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
    Martín J; Minor PD
    J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.
    Rezapkin GV; Douthitt M; Dragunsky E; Chumakov KM
    Virus Res; 1999 Dec; 65(2):111-9. PubMed ID: 10581384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.